PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsSynthetic biology could provide solution to bird flu

BioNews

Synthetic biology could provide solution to bird flu

Published 15 April 2013 posted in News and appears in BioNews 700

Author

David Gerard O'Rourke

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Synthetic biology is being used in the hunt for a vaccine for H7N9, the new strain of bird flu emerging in China, with hopes it could shave a vital two weeks off the development process...

Synthetic biology is being
used in the hunt for a vaccine for H7N9, the new strain of bird flu emerging in
China, with hopes it could shave a vital two weeks off the vaccine's development process.

Using
genetic sequence information posted on the website of the
Global Initiative on Sharing Avian Influenza Data (GISAID), Synthetic Genomics and Novartis have been working on the development of a synthetic vaccine to
protect against H7N9.

The
scientists are attempting to create a vaccine that mimics the real virus, but
importantly removing the pathogenic parts, allowing the body to develop
specific immunity without contracting the flu. This method will take two weeks
off the development process - critical when dealing with the rapid spread of an influenza pandemic.

Vaccine
manufacturers normally rely on the World Health Organisation (WHO) to identify
and distribute live viruses to create vaccines, while synthetic biology only requires the genetic sequence of
the virus.

'The early
availability of these synthetic genes could more rapidly and effectively assist
in a global response to an emerging flu strain', said Craig Venter, CEO of
Synthetic Genomics.

Learning
from mistakes made during the SARS outbreak, scientists
speedily identified that the zoonotic virus originated
from a poultry market, sequenced its DNA and published the results online within
six days.

From the genome
sequence, many gene variants were identified, giving clues to the kind of
threat the disease may pose. The mutation R292K, which causes a high-level
resistance to the influenza drug Tamiflu and reduced sensitivity to Relenza,
was shown to be present in a sample obtained from one patient in Shanghai.

The sequencing
also showed the presence of the gene mutation Q226L, which indicates the
ability to infect mammals. Q226L could
enhance the ability of the virus to bind to receptors in the human upper air
tract and was associated with the transmission of the H5N1 virus in 2009.

To date, 60
people have been infected and 13 killed by H7N9 since the new form of the virus
was confirmed on 31 March 2013. There is still no evidence to suggest that it
can spread from human to human, and experts believe that direct contact with diseased
poultry accounts for the human cases. This has resulted in the slaughter of 20,000
birds in Shanghai and the closure of live chicken markets in both Shanghai and
Beijing as the capital confirms its first case.

Michael O'Leary,
the WHO's representative in China, said: 'There's no way to predict how it will
spread but it's not surprising if we have new cases in different places like we
do in Beijing'.

Related Articles

PET BioNews
News
19 June 2017 • 2 minutes read

Three mutations could make bird flu more infectious to humans

by Jonathan Bestwick

Scientists have identified three potential genetic mutations that could allow a dangerous strain of avian influenza to spread between humans...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
18 September 2015 • 3 minutes read

Radio Review: FutureProofing - Life

by Ross Cloney

The key question of the 21st century may turn out to be: 'Who are we and what will we become?' This question and the implications of its potential answers are explored in 'FutureProofing: Life', which sets out to understand the field of synthetic biology...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 August 2014 • 2 minutes read

Ebola virus is mutating fast, gene studies find

by Siobhan Chan

The ebola virus has accumulated hundreds of mutations since the beginning of the current outbreak, researchers analysing the viral genome have found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 May 2014 • 2 minutes read

'Humanised' lungs for transplant patients to be grown in pigs

by Claire Downes

The shortage of transplantable lungs available for people with end-stage lung disease is being addressed in a new project led by genome scientist Dr Craig Venter...

PET BioNews
News
28 March 2014 • 3 minutes read

Synthetic biology moves beyond bacteria and viruses with 'man-made' yeast chromosome

by Rhys Baker

The world's first fully-functional synthetic yeast chromosome has been created in an international seven-year effort...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 March 2013 • 2 minutes read

Controversial publication of bird flu studies reveal virus' potential

by Dr Greg Ball

Controversial research showing how the H5N1 'bird flu' virus can be altered to make it transmissible between mammals through the air has been published, nine months after it was first presented at a conference....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 February 2013 • 2 minutes read

Genetic flaw raises flu risk

by Dr Nadeem Shaikh

Differences in the severity of people's flu symptoms may be due to a genetic variant, according to scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 February 2013 • 2 minutes read

Gene variant may explain increased flu severity among Chinese

by Matthew Thomas

A genetic variant frequently found in Chinese populations may explain why severe complications from swine flu are more common in China. The discovery may also have implications for other influenza virus strains and help scientists understand why flu outbreaks hit some populations harder than others....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
26 August 2011 • 2 minutes read

Genetic link found to resistance to the flu

by Zara Mahmoud

Scientists have suggested there may be a genetic basis behind the way our body reacts to the flu virus, making some of us more vulnerable than others. A study published in PLoS Genetics has tracked the body's response to the H3N2/Wisconsin strain of the flu virus at the genetic level. The researchers injected the virus into 17 volunteers and analysed expression patterns from the time of injection to the onset of full-blown clinical symptoms...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« British scientists move closer to womb transplant

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Common virus may be cause of recent hepatitis cases in children

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

1 August 2022 • 2 minutes read

CRISPR genome editing treatments may raise cancer risk

1 August 2022 • 2 minutes read

Differences in IVF-conceived children's size disappear by adolescence

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856